- Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry
-
Kim HA, Park SY, Shin K
- KMID: 2533622
- J Rheum Dis.
- 2022 Oct;29(4):215-222.
- doi: 10.4078/jrd.22.0005
Objective: This study aimed to assess the prevalence of pain in patients with RA in clinical remission and analyze the demographic and clinical characteristics of those who experienced persistent pain... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy
-
Kim HA, Lee E, Park SY, Lee SS, Shin K
- KMID: 2532628
- J Korean Med Sci.
- 2022 Aug;37(33):e253.
- doi: 10.3346/jkms.2022.37.e253
Background: Clinical characteristics and manifestations of psoriatic arthritis (PsA) have been extensively studied in western countries, yet data of Korean patients with PsA are very limited. We aimed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients
-
Joo YB, Jeong SM, Park YJ, Kim KJ, Park KS
- KMID: 2530680
- J Rheum Dis.
- 2022 Jul;29(3):162-170.
- doi: 10.4078/jrd.2022.29.3.162
Objective: There is no recommendation for the use of disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) who developed cancer. We examined changes in the DMARDs prescription patterns... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy:a Prospective Single Center Cohort Study
-
Song YJ, Cho SK, Kim H, Kim HW, Nam E, Bae SC, Yoo DH, Sung YK
- KMID: 2513707
- J Korean Med Sci.
- 2021 Mar;36(10):e70.
- doi: 10.3346/jkms.2021.36.e70
Background: Patients with rheumatoid arthritis (RA) undergoing targeted therapy have a higher risk of developing tuberculosis (TB). This requires diagnosis and treatment of latent tuberculosis infection (LTBI). We aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Biologic therapies for the treatment of rheumatoid arthritis
-
Choi SJ
- KMID: 2513063
- J Korean Med Assoc.
- 2021 Feb;64(2):95-104.
- doi: 10.5124/jkma.2021.64.2.95
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the synovial joints. If left untreated, persistent synovial inflammation can lead to cartilage and bone destruction, ultimately causing significant... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
-
Park EJ, Kim H, Jung SM, Sung YK, Baek HJ, Lee J
- KMID: 2501985
- Korean J Intern Med.
- 2020 Jan;35(1):41-59.
- doi: 10.3904/kjim.2019.411
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Minimization Analysis of Biologic Disease-Modifying Antirheumatic Drugs Administered by Subcutaneous Injections in Patients with Rheumatoid Arthritis
-
Park SH, Lee MY, Lee EK
- KMID: 2226432
- Korean J Clin Pharm.
- 2016 Mar;26(1):59-69.
- doi: 10.0000/kjcp.2016.26.1.59
BACKGROUND: The subcutaneous formulation of biologic disease-modifying antirheumatic drugs (DMARDs) was preferred due to favored self-administration and would be an economical treatment option for patients with rheumatoid arthritis. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effectiveness of Biologic DMARDs in Rheumatoid Arthritis Patients with Inadequate Response to conventional DMARDs: Using a Bayesian Network Meta-analysis
-
Park SK, Kim HL, Lee MY, Kim A, Lee EK
- KMID: 2226396
- Korean J Clin Pharm.
- 2015 Mar;25(1):9-17.
- doi: 10.0000/kjcp.2015.25.1.9
BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) extend the treatment choices for rheumatoid arthritis patients with insufficient response or intolerance to conventional DMARDs (cDMARDs). These agents have considerable efficacy compared with... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of juvenile rheumatoid arthritis
-
Kim KN
- KMID: 2280906
- Korean J Pediatr.
- 2010 Nov;53(11):936-941.
- doi: 10.3345/kjp.2010.53.11.936
The systematic approach to pharmacologic treatment is typically to begin with the safest, simplest, and most conservative measures. It has been realized that the more rapidly inflammation is under control,... -
- CITED
-
- Close
- SHARE
-
- Close
- Rheumatoid Factor is a Marker of Disease Severity in Korean Rheumatoid Arthritis
-
Shin YS, Choi JH, Nahm DH, Park HS, Cho JH, Suh CH
- KMID: 1716514
- Yonsei Med J.
- 2005 Aug;46(4):464-470.
- doi: 10.3349/ymj.2005.46.4.464
Serum rheumatoid factor (RF) is important in the diagnosis and prognosis of rheumatoid arthritis (RA). The purpose of this study is to compare the clinical characteristics and treatment patterns of... -
- CITED
-
- Close
- SHARE
-
- Close
- Disease Modifying Antirheumatic Drugs in Rheumatoid Artritis
-
Suh CH
- KMID: 2168064
- Hanyang Med Rev.
- 2005 May;25(2):73-79.
Rheumatoid arthritis (RA) is a chronic progressive disease, affecting an estimated 1% of the population worldwide. Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone... -
- CITED
-
- Close
- SHARE
-
- Close
- Paradigm Shifting to Early Treatment of Rheumatoid Arthritis
-
Park MC, Lee SK
- KMID: 2183129
- J Korean Med Assoc.
- 2003 Nov;46(11):965-971.
- doi: 10.5124/jkma.2003.46.11.965
The past decade has greatly enhanced our understanding of rheumatoid arthritis (RA). Not only have new drug therapies become available, but this period has witnessed dramatic changes in treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Therapy for Rheumatoid Arthritis
-
Min DJ
- KMID: 2065104
- J Korean Med Assoc.
- 2003 Feb;46(2):147-154.
- doi: 10.5124/jkma.2003.46.2.147
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovitis and damage of bone and cartilage. The major goals of therapy in RA are to relieve pain, swelling of... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Treatment of Rheumatoid Arthritis
-
Lee YH, Song GG
- KMID: 2015016
- J Korean Geriatr Soc.
- 1999 Jun;3(1):7-14.
Rheumatoid arthritis is a chronic inflammatory disease and afflicts approximately 1% of general population. Once considered as a benign non-fatal disease, rheumatoid arthritis is a debilitating condition with a serious... -
- CITED
-
- Close
- SHARE
-
- Close
